DK0889880T3 - Eprosartan-dihydrat og fremgangsmåde til fremstilling deraf samt formulering - Google Patents

Eprosartan-dihydrat og fremgangsmåde til fremstilling deraf samt formulering

Info

Publication number
DK0889880T3
DK0889880T3 DK97917004T DK97917004T DK0889880T3 DK 0889880 T3 DK0889880 T3 DK 0889880T3 DK 97917004 T DK97917004 T DK 97917004T DK 97917004 T DK97917004 T DK 97917004T DK 0889880 T3 DK0889880 T3 DK 0889880T3
Authority
DK
Denmark
Prior art keywords
formulation
preparation
eprosartan
dihydrate
eprosartan dihydrate
Prior art date
Application number
DK97917004T
Other languages
English (en)
Inventor
Nageswara R Palepu
Gopadi M Venkatesh
Sarma Duddu
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21765344&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0889880(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of DK0889880T3 publication Critical patent/DK0889880T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
DK97917004T 1996-03-29 1997-03-26 Eprosartan-dihydrat og fremgangsmåde til fremstilling deraf samt formulering DK0889880T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1441496P 1996-03-29 1996-03-29
PCT/US1997/004877 WO1997036874A1 (en) 1996-03-29 1997-03-26 Eprosartan dihydrate and a process for its production and formulation

Publications (1)

Publication Number Publication Date
DK0889880T3 true DK0889880T3 (da) 2003-09-01

Family

ID=21765344

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97917004T DK0889880T3 (da) 1996-03-29 1997-03-26 Eprosartan-dihydrat og fremgangsmåde til fremstilling deraf samt formulering

Country Status (36)

Country Link
EP (1) EP0889880B1 (da)
JP (1) JP4316013B2 (da)
CN (2) CN1214682A (da)
AP (1) AP901A (da)
AR (1) AR006439A1 (da)
AT (1) ATE239723T1 (da)
AU (1) AU726694B2 (da)
BG (1) BG64095B1 (da)
BR (1) BR9708336A (da)
CA (1) CA2250395C (da)
CZ (1) CZ293345B6 (da)
DE (1) DE69721749T2 (da)
DK (1) DK0889880T3 (da)
DZ (1) DZ2199A1 (da)
EA (1) EA001958B1 (da)
EG (1) EG23889A (da)
ES (1) ES2198564T3 (da)
HK (1) HK1016594A1 (da)
HU (1) HU228263B1 (da)
ID (1) ID16507A (da)
IL (1) IL126319A0 (da)
MA (1) MA24437A1 (da)
MY (1) MY117682A (da)
NO (2) NO311760B1 (da)
NZ (1) NZ332008A (da)
OA (1) OA11176A (da)
PL (1) PL188816B1 (da)
PT (1) PT889880E (da)
RO (1) RO118870B1 (da)
SK (1) SK282346B6 (da)
TR (1) TR199801954T2 (da)
TW (1) TW434239B (da)
UA (1) UA49880C2 (da)
UY (1) UY24504A1 (da)
WO (1) WO1997036874A1 (da)
ZA (1) ZA972686B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4475685B2 (ja) * 1997-06-27 2010-06-09 スミスクライン・ビーチャム・コーポレイション エプロサルタン・一水和物
JP4880118B2 (ja) * 1997-11-17 2012-02-22 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 薬物高充填性の即時放出性または放出を修飾した経口用投与処方およびその製法
US6558699B2 (en) * 1997-11-17 2003-05-06 Smithkline Beecham Corporation High drug load immediate and modified release oral dosage formulations and processes for their manufacture
BR9908474A (pt) 1998-03-04 2000-12-05 Takeda Chemical Industries Ltd Preparação de liberação prolongada, processo para a produção de uma preparação de liberação prolongada, e, composição farmacêutica
ZA991922B (en) * 1998-03-11 1999-09-13 Smithkline Beecham Corp Novel compositions of eprosartan.
IL140905A0 (en) * 1998-07-20 2002-02-10 Smithkline Beecham Corp Bioenhanced formulations comprising eprosartan in oral solid dosage form
GB9820405D0 (en) * 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
WO2000027396A1 (en) * 1998-11-06 2000-05-18 Glaxo Group Limited Medicaments based on combinations of lacidipine and telmisartan or of physiological derivatives thereof
WO2000027397A1 (en) * 1998-11-06 2000-05-18 Glaxo Group Limited Antihypertensive medicaments containing lacidipine and telmisartan
EP1197223B1 (en) * 1999-04-28 2005-02-16 Takeda Pharmaceutical Company Limited Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
AR032152A1 (es) * 2000-04-12 2003-10-29 Novartis Ag Uso de una combinacion de compuestos terapeuticos organicos para la fabricacion de un medicamento, un agente terapeutico, y una composicion farmaceutica
WO2003043615A2 (de) * 2001-11-23 2003-05-30 Solvay Pharmaceuticals Gmbh Hypertoniebehandlung während der akuten phase des schlaganfalls
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
PL373202A1 (en) * 2002-05-17 2005-08-22 Novartis Ag Combination of angiotensin ii receptor blocker and beta-blocker for secondary prevention of myocardial infarction
EG24716A (en) 2002-05-17 2010-06-07 Novartis Ag Combination of organic compounds
DE10230272A1 (de) * 2002-07-05 2004-01-22 Solvay Pharmaceuticals Gmbh AT1-Rezeptorantagonisten zur Prävention von Folgeschlaganfällen
BRPI0406987A (pt) 2003-01-31 2006-01-10 Sankyo Co Medicamento para a prevenção e/ou tratamento de arteriosclerose, medicamentos para a inibição de proliferação de células do músculo liso vascular, de formação de neoìntima dos vasos sanguìneos e de remodelação vascular, medicamento para a prevenção de restenose que segue intervenção coronária percutânea, e, medicamentos para a profilaxia e/ou tratamento de hipertensão ou doenças causadas por hipertensão ou doenças causadas por hipertensão, de doenças cardìacas, de angina do peito, de infarto miocárdico, de arritmia, de morte súbita, de insuficiência cardìaca, de hipertrofia cardìaca, de doenças renais, de nefropatia diabética, de glomerulonefrite, de nefrosclerose, de doenças cerebrovasculares, de infarto cerebral, e de hemorragia cerebral
EP2181109A4 (en) 2007-07-25 2011-08-03 Hetero Drugs Ltd CRYSTALLINE PARTICLES OF EPROSARTAN MESYLATE AND PROCESS FOR PREPARING PURE EPROSARTAN
WO2009084028A2 (en) * 2007-12-03 2009-07-09 Neuland Laboratories Ltd Improved process for manufacturing anhydrous (e)-3-[2-butyl-1- {(4-carboxyphenyl) methyl}-1h-imidazole-5-yl]-(thiophen-2- ylmethyl)prop-2-enoic acid methane sulfonate
CN101333216A (zh) * 2008-08-03 2008-12-31 浙江华海药业股份有限公司 一种新的依普罗沙坦甲磺酸盐成盐工艺
CN113354553B (zh) * 2021-06-03 2023-09-15 北京宝诺康医药科技有限公司 一种甲氧氯普胺单盐酸盐一水合物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
US5312828A (en) * 1989-06-14 1994-05-17 Finkelstein Joseph A Substituted imidazoles having angiotensin II receptor blocking activity
JP3214856B2 (ja) * 1990-12-14 2001-10-02 スミスクライン・ビーチャム・コーポレイション イミダゾリル−アルケン酸

Also Published As

Publication number Publication date
PL188816B1 (pl) 2005-04-29
BR9708336A (pt) 1999-08-03
BG64095B1 (bg) 2003-12-31
EA199800873A1 (ru) 1999-02-25
EP0889880A1 (en) 1999-01-13
CZ293345B6 (cs) 2004-04-14
SK282346B6 (sk) 2002-01-07
HK1016594A1 (en) 1999-11-05
HU228263B1 (en) 2013-02-28
CA2250395C (en) 2005-09-06
DE69721749T2 (de) 2004-03-25
AP9700956A0 (en) 1997-04-30
NO2002005I1 (no) 2002-09-02
NO984503D0 (no) 1998-09-28
SK132298A3 (en) 1999-03-12
EA001958B1 (ru) 2001-10-22
EG23889A (en) 2007-12-12
CA2250395A1 (en) 1997-10-09
UY24504A1 (es) 1997-09-19
CZ310198A3 (cs) 1999-03-17
JP2000508632A (ja) 2000-07-11
RO118870B1 (ro) 2003-12-30
AP901A (en) 2000-11-23
WO1997036874A1 (en) 1997-10-09
DE69721749D1 (de) 2003-06-12
TR199801954T2 (xx) 1998-12-21
ZA972686B (en) 1997-09-29
JP4316013B2 (ja) 2009-08-19
OA11176A (en) 2003-05-13
TW434239B (en) 2001-05-16
AU726694B2 (en) 2000-11-16
HUP9902769A3 (en) 2000-04-28
EP0889880B1 (en) 2003-05-07
EP0889880A4 (en) 1999-06-23
AU2547097A (en) 1997-10-22
CN1214682A (zh) 1999-04-21
CN1332167A (zh) 2002-01-23
IL126319A0 (en) 1999-05-09
ES2198564T3 (es) 2004-02-01
BG102822A (en) 1999-11-30
MA24437A1 (fr) 1998-10-01
MY117682A (en) 2004-07-31
NZ332008A (en) 1999-05-28
ATE239723T1 (de) 2003-05-15
DZ2199A1 (fr) 2002-12-03
ID16507A (id) 1997-10-02
NO311760B1 (no) 2002-01-21
UA49880C2 (uk) 2002-10-15
NO984503L (no) 1998-09-28
AR006439A1 (es) 1999-08-25
HUP9902769A2 (hu) 2000-03-28
PT889880E (pt) 2003-09-30
PL329046A1 (en) 1999-03-01

Similar Documents

Publication Publication Date Title
DK0889880T3 (da) Eprosartan-dihydrat og fremgangsmåde til fremstilling deraf samt formulering
DK1112174T3 (da) Isosorbidholdige polyestere og fremgangsmåder til fremstiling heraf
DK0850948T3 (da) Propiophenonderivater og fremgangsmåde til fremstilling deraf
DE69634256D1 (de) Zementformulierung
NO983766D0 (no) FremgangsmÕte til fremstilling av N-acetyl-D-glukosamin
DK0739898T3 (da) Phosphononmoneosternukleinsyrer, fremgangsmåde til fremstilling deraf og anvendelse deraf
NO974528D0 (no) Sementeringsslurry og fremgangsmåte til utforming av formulering
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
DK0980240T3 (da) Sammensætninger med lang frigivelse og fremgangsmåde til fremstilling heraf
DK0985697T3 (da) Oxiranderivater og fremgangsmåde til fremstilling deraf
EE9900014A (et) Erütromütsiinid ja nende valmistamise protsess
DK0799052T3 (da) Ny antihrombotisk formulering, fremgangsmåde til dens fremstilling og anvendelse deraf
DK0926952T3 (da) Antimikrobiel sammensætning og fremgangsmåde til fremstilling deraf
DK1015444T3 (da) Pyrimidinderivater og fremgangsmåder til fremstilling deraf
ID22755A (id) Proses prapengolahan kosmetik bekas
DK0991666T3 (da) Alfa-1-antitrypsin-præparat og fremgangsmåde til fremstilling heraf
DK0977812T3 (da) Asfaltsammensætninger og fremgangsmåder til fremstilling deraf
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO20002202D0 (no) Støpte polyolefin- og polyfenyloksidprodukter og fremgangsmÕte til fremstilling derav
NO985385D0 (no) Bitumensammensetninger og fremgangsmÕte for fremstilling derav
DK1003383T3 (da) Smagsforstærkende N-ethyl-p-menthan-3-carboxamidindeholdende forbindelser og fremgangsmåde til fremstilling og anvendelse deraf
DK0735042T3 (da) Maltitolsammensætning og fremgangsmåde til fremstilling deraf
ID18793A (id) Bahan penahan untuk pestisida
DK0933373T3 (da) Terpenoidlactonforbindelser og fremgangsmåder til fremstilling deraf
DK0791591T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder til deres fremstilling